Is the Galleri multi-cancer blood test worth it? A doctor explains real-world performance data and explains why no major medical society recommends the test for screening.

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leader in cancer diagnostics, today announced the launch of the Cancerguard™ test, a new multi-cancer early detection (MCED) ...

Dec. 2 (UPI) --As new blood tests capable of detecting dozens of cancers in their early stages are hitting the market, disease prevention advocates say political and economic momentum is building for ...

MENLO PARK, Calif.--(BUSINESS WIRE)--GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can be cured, today announced that detailed findings from the PATHFINDER study of ...

VERICHEM LABORATORIES now offers two multi-level test kits of clinical reference materials for the calibration verification of Lithium assays. The kits, the Electrolyte Standard Kit (List No. 9200) ...